Suppr超能文献

人类还原型叶酸载体基因受AP2和sp1转录因子家族以及一个功能性61碱基对多态性的调控。

The human reduced folate carrier gene is regulated by the AP2 and sp1 transcription factor families and a functional 61-base pair polymorphism.

作者信息

Whetstine Johnathan R, Witt Teah L, Matherly Larry H

机构信息

Department of Pharmacology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

出版信息

J Biol Chem. 2002 Nov 15;277(46):43873-80. doi: 10.1074/jbc.M208296200. Epub 2002 Sep 12.

Abstract

Recently, our laboratory reported an intricate regulation of the human reduced folate carrier (hRFC) gene, involving multiple promoters and noncoding exons. We localized promoter activity to a 452-bp GC-rich region upstream of noncoding exon A, including a 47-bp basal promoter with a CRE/AP-1-like consensus element that bound the bZip family of DNA-binding proteins (e.g. CREB-1 and c-Jun). We now report that three nearly identical tandem repeats (49-61 bp) in the hRFC-A upstream region are involved in regulating promoter activity. By in vitro binding assays, multiple transcription factors (e.g. AP2 and Sp1/Sp3) bound this region. When AP2 was cotransfected with the hRFC-A reporter construct into HT1080 cells, promoter activity increased 3-fold. In Drosophila SL2 cells, Sp1 transactivated promoter A and showed synergism with CREB-1. However, c-Jun was antagonistic to the effects of Sp1. A sequence variant in the hRFC-A repeated region was identified, involving an exact duplication of a 61-bp sequence. This variant had an allelic frequency of 78% in 72 genomic DNAs and resulted in a 63% increase in promoter activity. These results identify important regions in the hRFC-A promoter and critical roles for AP2 and Sp1, in combination with the bZip transcription factors. Moreover, they document a functionally novel polymorphism that increases promoter activity and may contribute to interpatient variations in hRFC expression and effects on tissue folate homeostasis and antitumor response to antifolates.

摘要

最近,我们实验室报道了人类还原型叶酸载体(hRFC)基因的复杂调控机制,该机制涉及多个启动子和非编码外显子。我们将启动子活性定位于非编码外显子A上游一个452bp富含GC的区域,其中包括一个47bp的基础启动子,该启动子具有一个CRE/AP-1样共有元件,可与DNA结合蛋白的bZip家族(如CREB-1和c-Jun)结合。我们现在报道,hRFC-A上游区域的三个几乎相同的串联重复序列(49-61bp)参与调控启动子活性。通过体外结合试验,多种转录因子(如AP2和Sp1/Sp3)可结合该区域。当将AP2与hRFC-A报告基因构建体共转染到HT1080细胞中时,启动子活性增加了3倍。在果蝇SL2细胞中,Sp1可激活启动子A,并与CREB-1表现出协同作用。然而,c-Jun对Sp1的作用具有拮抗作用。在hRFC-A重复区域鉴定出一个序列变异,涉及一个61bp序列的精确重复。该变异在72个基因组DNA中的等位基因频率为78%,并导致启动子活性增加63%。这些结果确定了hRFC-A启动子中的重要区域以及AP2和Sp1与bZip转录因子结合的关键作用。此外,它们记录了一种功能上新的多态性,该多态性增加了启动子活性,并可能导致患者间hRFC表达的差异以及对组织叶酸稳态和抗叶酸抗肿瘤反应的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验